# ICS Medical Advisory (ICSMA-19-311-02)
## Medtronic Valleylab FT10 and FX8
Original release date: November 07, 2019
[Print Document](javascript:window.print\(\);)
[Tweet](https://twitter.com/share?url=https%3A%2F%2Fus-
cert.cisa.gov%2Fics%2Fadvisories%2Ficsma-19-311-02)
[Like Me](https://www.facebook.com/sharer.php?u=https%3A%2F%2Fus-
cert.cisa.gov%2Fics%2Fadvisories%2Ficsma-19-311-02)
[Share](http://www.addthis.com/bookmark.php?url=https%3A%2F%2Fus-
cert.cisa.gov%2Fics%2Fadvisories%2Ficsma-19-311-02)
### Legal Notice
All information products included in [https://us-cert.gov/ics](/ics) are
provided "as is" for informational purposes only. The Department of Homeland
Security (DHS) does not provide any warranties of any kind regarding any
information contained within. DHS does not endorse any commercial product or
service, referenced in this product or otherwise. Further dissemination of
this product is governed by the Traffic Light Protocol (TLP) marking in the
header. For more information about TLP, see [https://www.us-
cert.gov/tlp/](/tlp/).
* * *
## 1\. EXECUTIVE SUMMARY
* **CVSS v3 9.8**
* **ATTENTION:** Exploitable remotely/low skill level to exploit
* **Vendor:** Medtronic
* **Equipment:** Valleylab FT10, Valleylab FX8
* **Vulnerabilities:** Use of Hard-coded Credentials, Reversible One-way Hash, Improper Input Validation
## 2\. RISK EVALUATION
Successful exploitation of these vulnerabilities may allow an attacker to
overwrite files or remotely execute code, resulting in a remote, non-root
shell on the affected products. By default, the network connections on these
devices are disabled. Additionally, the Ethernet port is disabled upon reboot.
However, it is known that network connectivity is often enabled.
## 3\. TECHNICAL DETAILS
### 3.1 AFFECTED PRODUCTS
The following Medtronic Valleylab products, are affected:
* Valleylab Exchange Client, Version 3.4 and below
* Valleylab FT10 Energy Platform (VLFT10GEN) software Version 4.0.0 and below
* Valleylab FX8 Energy Platform (VLFX8GEN) software Version 1.1.0 and below
### 3.2 VULNERABILITY OVERVIEW
#### 3.2.1 [USE OF HARD-CODED CREDENTIALS
CWE-798](https://cwe.mitre.org/data/definitions/798.html)
The affected products use multiple sets of hard-coded credentials. If
discovered, they can be used to read files on the device.
[CVE-2019-13543](http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2019-13543)
has been assigned to this vulnerability. A CVSS v3 base score of 5.8 has been
calculated; the CVSS vector string is
([AV:N/AC:L/PR:N/UI:N/S:C/C:L/I:N/A:N](https://www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:C/C:L/I:N/A:N)).
#### 3.2.2 [REVERSIBLE ONE-WAY HASH
CWE-328](https://cwe.mitre.org/data/definitions/328.html)
The affected products use the descrypt algorithm for OS password hashing.
While interactive, network-based logons are disabled, and attackers can use
the other vulnerabilities within this report to obtain local shell access and
access these hashes.
[CVE-2019-13539](http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2019-13539)
has been assigned to this vulnerability. A CVSS v3 base score of 7.0 has been
calculated; the CVSS vector string is
([AV:L/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H](https://www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:L/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H)).
#### 3.2.3 [IMPROPER INPUT VALIDATION
CWE-20](https://cwe.mitre.org/data/definitions/20.html)
The affected products use a vulnerable version of the rssh utility in order to
facilitate file uploads. This could provide an attacker with administrative
access to files or the ability to execute arbitrary code.
[CVE-2019-3464](http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2019-3464),
and
[CVE-2019-3463](http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2019-3463)
have been assigned to this vulnerability. A CVSS v3 base score of 9.8 has been
calculated; the CVSS vector string is
([AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H](https://www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H)).
### 3.3 BACKGROUND
* **CRITICAL INFRASTRUCTURE SECTORS:** Healthcare and Public Health
* **COUNTRIES/AREAS DEPLOYED:** Worldwide
* **COMPANY HEADQUARTERS LOCATION:** Ireland
### 3.4 RESEARCHER
Medtronic reported these vulnerabilities to CISA.
## 4\. MITIGATIONS
Software patches are currently available for the FT10 platform and will be
available in early 2020 for the FX8 platform. Until these updates can be
applied, Medtronic recommends to either disconnect affected products from IP
networks or to segregate those networks, such that the devices are not
accessible from an untrusted network (e.g., Internet). Patches can be
downloaded at the following location:
<https://www.medtronic.com/covidien/en-us/support/software.html>
Medtronic has released additional patient focused information, at the
following location:
<https://www.medtronic.com/security>
CISA recommends users take defensive measures to minimize the risk of
exploitation of these vulnerabilities. Specifically, users should:
* Minimize network exposure for all medical devices and/or systems.
* Locate medical devices behind firewalls and isolate them where possible.
* Restrict system access to authorized personnel only and follow a least privilege approach.
* Apply defense-in-depth strategies.
* Disable any unnecessary accounts, protocols and services.
* Where additional information is needed, refer to existing cybersecurity in medical device guidance issued by the FDA at the following location: <https://www.fda.gov/medical-devices/digital-health/cybersecurity>
CISA reminds organizations to perform proper impact analysis and risk
assessment prior to deploying defensive measures.
CISA also provides a section for [control systems security recommended
practices](https://www.us-cert.gov/ics/recommended-practices) on the ICS
webpage on [us-cert.gov](https://www.us-cert.gov/ics). Several recommended
practices are available for reading and download, including [Improving
Industrial Control Systems Cybersecurity with Defense-in-Depth
Strategies](https://www.us-
cert.gov/sites/default/files/recommended_practices/NCCIC_ICS-
CERT_Defense_in_Depth_2016_S508C.pdf).
Additional mitigation guidance and recommended practices are publicly
available on the [ICS webpage on us-cert.gov](https://www.us-cert.gov/ics) in
the Technical Information Paper, [ICS-TIP-12-146-01B--Targeted Cyber Intrusion
Detection and Mitigation Strategies](https://www.us-cert.gov/ics/tips/ICS-
TIP-12-146-01B).
Organizations observing any suspected malicious activity should follow their
established internal procedures and report their findings to CISA for tracking
and correlation against other incidents.
No known public exploits specifically target these vulnerabilities.
暂无评论